tirzepatide surmount-1 trial weight loss non-diabetic for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled SURMOUNT-1 Trial Summary: What Tirzepatide

What is sublingual methyl B12

Understanding the reasons behind this tiredness and finding ways to combat it can help you manage your symptoms better

In remote-controlled models, electric drones, and aviation model equipment, the charging time of LiPo batteries has always been one of the key concerns for users

Ozempic is one of many glucagon-like peptide 1 (GLP-1) agonist drugs used to lower blood sugar levels

To sort out what's safe, what's risky, and what the evidence actually shows, I turned to Oluwatosin Ajao, MD, an obesity medicine physician known to her patients as Dr

ABOM, Chief Medical Officer at eMed, who will share insights from the front lines of patient care, clinical support and innovation in this rapidly evolving space